BackGeneDx Holdings Overview

GeneDx Holdings Inventory

Track GeneDx Holdings's inventory ($18M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$17.82M
↑ 49.35% YoYΔ $5.89M vs prior year quarter

Peer average / median

Loading

GeneDx Holdings Inventory History

Loading

GeneDx Holdings vs. peers: Inventory Comparison

Loading

GeneDx Holdings Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GeneDx Holdings (SMFR) FAQ

GeneDx Holdings (SMFR) currently reports a inventory of $18M as of June 2026. That compares with $12M in the prior-year period — up 49.3% year over year. Use the charts on this page to explore GeneDx Holdings's inventory history and peer comparisons.

GeneDx Holdings's inventory increased from $12M to $18M — a 49.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GeneDx Holdings reported $18M in inventory as of June 2026. That compares with $12M in the prior-year period — up 49.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GeneDx Holdings, and consider following SMFR for alerts when major investors trade the stock.

GeneDx Holdings is classified in the Healthcare sector. On inventory, it currently shows $18M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SMFR with unrelated industries.